Brief: Regulus Therapeutics Initiates Preclinical Studies In Amyotrophic Lateral Sclerosis Under Collaboration Agreement With Harvard's Brigham And Women's Hospital

Regulus Therapeutics

24/03/2022 12:50

March 24 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL
STUDIES
IN AMYOTROPHIC LATERAL SCLEROSIS UNDER A COLLABORATION AGREEMENT
WITH HARVARD'S BRIGHAM AND WOMEN'S HOSPITAL
    * REGULUS THERAPEUTICS INC - PRELIMINARY DATA ARE EXPECTED
IN
SECOND HALF OF 2022

Source text for Eikon:  ID:nPnbl2Tyqa 
Further company coverage:  RGLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))